Wegovy and Saxenda also have FDA approval for certain pediatric populations
Because obesity is a precursor to many other conditions, Black Californians experience disproportionately high rates of diabetes, hypertension, and cardiovascular disease
Eli Lilly finished their phase II trials for retatrutide and shared the results in June 2023
Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, Mills DA (2013) A comparison of two probiotic strains of bifidobacteria in premature infants
Circular and circulating DNA in inflammatory bowel disease: from pathogenesis to potential molecular therapies
This will ensure your comfort and confidence with the weight loss medication before you begin